This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent, primarily in Dermatological Treatments. Top assignees: Amderma Pharmaceuticals, LLC, Action Medicines, S.l., Other. Active years: 2012-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2019
Areas of Expertise:
Title: Rosa Maria Lozano Puerto: Innovator in Dermatological Treatments
Introduction
Rosa Maria Lozano Puerto is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of dermatology through her innovative research and development of therapeutic compounds. With a total of 17 patents to her name, she has established herself as a leading figure in the medical and pharmaceutical industries.
Latest Patents
Among her latest patents, Rosa has developed the use of 2,5-dihydroxybenzene derivatives for treating dermatitis. This invention focuses on the therapeutic and prophylactic treatment of dermatitis using a specific derivative represented by Formula (I) or its pharmaceutically acceptable variants. Additionally, she has patented the use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer, showcasing her commitment to addressing critical health issues.
Career Highlights
Rosa has worked with Amderma Pharmaceuticals, LLC, where she has contributed her expertise in dermatological research. Her work has been instrumental in advancing treatment options for skin-related conditions, making a positive impact on patient care.
Collaborations
Rosa has collaborated with notable professionals in her field, including Guillermo Gimenez Gallego and Serafin Valverde Lopez. These partnerships have further enhanced her research and development efforts.
Conclusion
Rosa Maria Lozano Puerto is a trailblazer in the field of dermatology, with a strong portfolio of patents that reflect her dedication to improving skin health. Her innovative work continues to inspire advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile